Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[New treatment and diagnostic test for multiple myeloma].

Rinsho byori. The Japanese journal of clinical pathology - 1 Apr 2014

Handa Hiroshi

Abstract excerpt

Multiple myeloma (MM) is a malignancy of plasma cells of the final maturation stage of B cells, characterized by atypical plasma cell proliferation in bone marrow and the production of monoclonal immunoglobulin. The history of chemotherapy for MM began in the early 1960s, when the efficacy of alkylating agents, particularly melphalan, was shown. High-dose therapy (HDT) has been the standard treatment for patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Genetic Testing
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to In Situ Hybridization, Fluorescence

Share to Multiple Myeloma

Share to Prognosis

Source

Identifiers

PMID: 25022063

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[New treatment and diagnostic test for multiple myeloma].PMID 25022063Read ↗

[Cytogenetic and molecular basis of multiple myeloma].Semantic proximity Read ↗

Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysisSemantic proximity Read ↗

Clinical implications of cytogenetic and molecular aberrations in multiple myelomaSemantic proximity Read ↗

Interpretation of cytogenetic results in multiple myeloma for clinical practiceSemantic proximity Read ↗

The Role of Epigenetics in the Development and Progression of Multiple MyelomaSemantic proximity Read ↗

Targeted therapy of multiple myeloma: the changing paradigm at the beginning of the new millennium.Semantic proximity Read ↗

Recent advances in cytogenetic characterization of multiple myelomaSemantic proximity Read ↗

Gene mutations in newly diagnosed multiple myeloma patients detected by next-generation sequencing technologySemantic proximity Read ↗

[Multiple myeloma: chromosomal abnormalities, clinical features and prognosis].Semantic proximity Read ↗

Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple MyelomaSemantic proximity Read ↗

Establishment and characterization of multiple myeloma cell lines from a single patient’s disease course immortalizes clonal heterogeneitySemantic proximity Read ↗

Biology and treatment of myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.